AIP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arteris Inc (AIP) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The business trends are good, but the stock is already extended after a sharp regular-session drop and there is no clear high-conviction entry signal from Intellectia signals. If forced to act now, I would not buy aggressively at this price; I would hold and wait for a cleaner entry. For a patient long-term investor, the fundamentals support interest, but the current setup is not ideal for immediate deployment of capital.
Technically, AIP is still in an overall bullish structure because SMA_5 > SMA_20 > SMA_200, which confirms an uptrend. However, momentum has cooled: the MACD histogram is positive but contracting, suggesting upside strength is fading. RSI_6 at 67.0 is near overbought territory but not yet a strong sell signal. Price closed at 29.69 versus prior close 29.75, after a regular-market decline of 5.28%, which shows short-term weakness despite the broader trend. Pivot support is 28.392, with resistance at 31.238 and 32.996. In short, trend remains constructive, but near-term momentum is mixed and the stock is not offering a clean momentum entry.
["Revenue in 2025/Q4 increased 30.01% YoY.", "Gross margin improved to 90.76%, showing strong operating quality.", "Northland reiterated Outperform and calls AIP a top pick for calendar 2026.", "Analyst raised the price target to $24 from $21 after a record-breaking quarter in bookings.", "Semiconductor IP demand is described as robust, with no significant competitor.", "Earnings are scheduled for 2026-05-12 after hours, which could act as a catalyst."]
["The stock was pressured by the ATM announcement.", "Net income remains negative at -$8.5M in the latest quarter.", "EPS is still negative at -0.19.", "Recent regular-session price action was weak at -5.28%.", "No recent news in the last week, so there is no fresh positive event catalyst.", "Hedge funds and insiders are both neutral, with no notable buying support.", "No recent congress trading data or influential figure trading activity was available."]
In 2025/Q4, Arteris posted revenue of $20.137M, up 30.01% YoY, which is a strong growth rate. Gross margin improved to 90.76%, an excellent sign of product quality and pricing power. However, the company is still unprofitable, with net income at -$8.504M and EPS at -0.19, so the business is growing but not yet delivering earnings. The latest quarter season is 2025/Q4, and the financial trend is clearly improving on the top line while profitability remains negative.
Analyst sentiment is positive. Northland’s Gus Richard raised the price target to $24 from $21 on February 13 after a record-breaking quarter in bookings and kept an Outperform rating. On February 20, he reiterated $24 and said the stock has been pressured by the ATM announcement, but also argued Arteris does not need to raise money and that demand is robust. Wall Street pros view: bullish on the company’s strategic position, growth, and lack of major competition; the main con is the ATM-related overhang and the fact that the stock is trading above the cited target, which reduces near-term upside appeal.
